BCL9 KD in DCIS.COM cells resulted in a reduction in vimentin and an increase in epithelial marker E-cadherin (Fig. 7a, Additional file 6: Figure S3A, and Additional file 8: Figure S5). This evidence concerns the gene VIM and ductal breast carcinoma in situ.